Article

IRS rules that eyeglasses, contact lenses are not taxable

The Internal Revenue Service (IRS) has ruled that eyeglasses and contact lenses are exempted from the medical device excise tax that will take affect on Jan. 1, 2013.

Washington, DC-The Internal Revenue Service (IRS) has ruled that eyeglasses and contact lenses are exempted from the medical device excise tax that will take affect on Jan. 1, 2013.

The IRS, in its final ruling on the excise tax earlier this month, outlined the regulations and definitions as to what medical devices would be taxed under the Health Care and Education Reconciliation Act of 2010 in conjunction with the Patient Protection and Affordable Care Act.

Within the 58-page document, the IRS cites the “retail exemption” (Section 4191 [b][2]) clause, which states that “the term ‘taxable medical device’ does not include eyeglasses, contact lenses, hearing aids, and any other medical device determined by the Secretary to be of a type that is generally purchased by the general public at retail for individual use.”

Under the proposed regulations, a device is considered to be non-taxable when the medical device is purchased by the general public “at retail for individual use” if the device is regularly available for purchase and used by consumers who are not medical professionals, and if the device’s design is not intended for use in a medical institution, office, or by medical professionals.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.